Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$77.25
+1.3%
$78.50
$64.00
$83.00
$45.35B1.074.50 million shs4.91 million shs
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$630.56
-0.3%
$625.60
$356.14
$688.12
$50.44B1.56680,001 shs266,134 shs
ResMed Inc. stock logo
RMD
ResMed
$271.22
+0.4%
$277.76
$199.92
$293.81
$39.71B0.85992,422 shs977,682 shs
Teleflex Incorporated stock logo
TFX
Teleflex
$120.65
+0.6%
$122.42
$108.90
$248.54
$5.33B1.08771,257 shs442,233 shs
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
0.00%+2.61%-6.31%-2.56%+14.65%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
0.00%-3.65%-2.30%+17.88%+23.53%
ResMed Inc. stock logo
RMD
ResMed
0.00%-1.06%-1.54%+4.76%+13.20%
Teleflex Incorporated stock logo
TFX
Teleflex
0.00%-2.05%-5.10%+1.62%-51.33%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$77.25
+1.3%
$78.50
$64.00
$83.00
$45.35B1.074.50 million shs4.91 million shs
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$630.56
-0.3%
$625.60
$356.14
$688.12
$50.44B1.56680,001 shs266,134 shs
ResMed Inc. stock logo
RMD
ResMed
$271.22
+0.4%
$277.76
$199.92
$293.81
$39.71B0.85992,422 shs977,682 shs
Teleflex Incorporated stock logo
TFX
Teleflex
$120.65
+0.6%
$122.42
$108.90
$248.54
$5.33B1.08771,257 shs442,233 shs
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
0.00%+2.61%-6.31%-2.56%+14.65%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
0.00%-3.65%-2.30%+17.88%+23.53%
ResMed Inc. stock logo
RMD
ResMed
0.00%-1.06%-1.54%+4.76%+13.20%
Teleflex Incorporated stock logo
TFX
Teleflex
0.00%-2.05%-5.10%+1.62%-51.33%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
2.70
Moderate Buy$86.6112.12% Upside
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
2.80
Moderate Buy$649.442.99% Upside
ResMed Inc. stock logo
RMD
ResMed
2.93
Moderate Buy$294.208.47% Upside
Teleflex Incorporated stock logo
TFX
Teleflex
2.00
Hold$141.5717.34% Upside

Current Analyst Ratings Breakdown

Latest TFX, EW, IDXX, and RMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/22/2025
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price TargetBuy$95.00 ➝ $85.00
9/18/2025
ResMed Inc. stock logo
RMD
ResMed
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$330.00
9/16/2025
ResMed Inc. stock logo
RMD
ResMed
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong-Buy
9/2/2025
ResMed Inc. stock logo
RMD
ResMed
CLSA
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHoldOutperform
8/15/2025
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$722.00 ➝ $765.00
8/11/2025
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral$510.00 ➝ $700.00
8/7/2025
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$84.00 ➝ $88.00
8/5/2025
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price TargetOverweight$722.00
8/5/2025
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$545.00 ➝ $785.00
8/4/2025
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$640.00
8/4/2025
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$550.00 ➝ $675.00
(Data available from 9/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$5.44B8.34$2.77 per share27.93$17.06 per share4.53
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$3.90B12.94$12.40 per share50.86$19.48 per share32.37
ResMed Inc. stock logo
RMD
ResMed
$5.15B7.72$11.24 per share24.13$40.70 per share6.66
Teleflex Incorporated stock logo
TFX
Teleflex
$3.05B1.75$25.51 per share4.73$92.11 per share1.31
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$4.17B$6.9511.1128.093.6772.96%15.01%11.56%10/23/2025 (Estimated)
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$887.87M$12.0152.5046.434.0924.41%64.42%29.89%10/30/2025 (Estimated)
ResMed Inc. stock logo
RMD
ResMed
$1.40B$9.5128.5226.181.8227.22%25.62%18.69%10/23/2025 (Estimated)
Teleflex Incorporated stock logo
TFX
Teleflex
$69.68M$4.2528.397.951.686.31%15.08%8.85%10/30/2025 (Estimated)

Latest TFX, EW, IDXX, and RMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/23/2025Q3 2025
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$0.59N/AN/AN/A$1.49 billionN/A
10/23/2025Q1 2026
ResMed Inc. stock logo
RMD
ResMed
$2.49N/AN/AN/A$1.33 billionN/A
8/4/2025Q2 2025
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$3.28$3.63+$0.35$3.63$1.06 billion$1.11 billion
7/31/2025Q4 2025
ResMed Inc. stock logo
RMD
ResMed
$2.47$2.55+$0.08$2.58$1.33 billion$1.35 billion
7/31/2025Q2 2025
Teleflex Incorporated stock logo
TFX
Teleflex
$3.36$3.73+$0.37$2.77$771.53 million$780.90 million
7/24/2025Q2 2025
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$0.62$0.67+$0.05$0.56$1.49 billion$1.53 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
N/AN/AN/AN/AN/A
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
N/AN/AN/AN/AN/A
ResMed Inc. stock logo
RMD
ResMed
$2.400.88%N/A25.24%13 Years
Teleflex Incorporated stock logo
TFX
Teleflex
$1.361.13%N/A32.00%N/A

Latest TFX, EW, IDXX, and RMD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/31/2025
ResMed Inc. stock logo
RMD
ResMed
quarterly$0.600.88%8/14/20258/14/20259/18/2025
7/31/2025
Teleflex Incorporated stock logo
TFX
Teleflex
quarterly$0.341.19%8/15/20258/15/20259/15/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
0.06
4.68
3.87
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
0.31
1.11
0.79
ResMed Inc. stock logo
RMD
ResMed
0.11
3.44
2.53
Teleflex Incorporated stock logo
TFX
Teleflex
0.42
2.41
1.44

Institutional Ownership

CompanyInstitutional Ownership
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
79.46%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
87.84%
ResMed Inc. stock logo
RMD
ResMed
54.98%
Teleflex Incorporated stock logo
TFX
Teleflex
95.62%

Insider Ownership

CompanyInsider Ownership
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
0.34%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
0.98%
ResMed Inc. stock logo
RMD
ResMed
0.71%
Teleflex Incorporated stock logo
TFX
Teleflex
1.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
15,800587.10 million585.10 millionOptionable
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
11,00080.00 million79.22 millionOptionable
ResMed Inc. stock logo
RMD
ResMed
10,600146.41 million145.38 millionOptionable
Teleflex Incorporated stock logo
TFX
Teleflex
14,10044.19 million43.57 millionOptionable

Recent News About These Companies

Teleflex Incorporated (NYSE:TFX) Receives $141.57 Average PT from Analysts
Why Teleflex (TFX) Stock Is Trading Lower Today
Teleflex (NYSE:TFX) Cut to Buy at Wall Street Zen
Should Value Investors Buy Teleflex (TFX) Stock?
Teleflex In 2025: A Company Trying To Reset

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Edwards Lifesciences stock logo

Edwards Lifesciences NYSE:EW

$77.25 +1.00 (+1.31%)
Closing price 03:59 PM Eastern
Extended Trading
$77.19 -0.05 (-0.07%)
As of 06:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

IDEXX Laboratories stock logo

IDEXX Laboratories NASDAQ:IDXX

$630.56 -1.66 (-0.26%)
Closing price 04:00 PM Eastern
Extended Trading
$630.69 +0.13 (+0.02%)
As of 05:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

ResMed stock logo

ResMed NYSE:RMD

$271.22 +0.95 (+0.35%)
Closing price 03:59 PM Eastern
Extended Trading
$270.78 -0.44 (-0.16%)
As of 06:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Teleflex stock logo

Teleflex NYSE:TFX

$120.65 +0.66 (+0.55%)
Closing price 03:59 PM Eastern
Extended Trading
$119.01 -1.64 (-1.36%)
As of 06:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.